Acutus Medical, Inc.
AFIB
$0.0538
$0.011828.10%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 532.48% | 717.57% | 1,512.84% | 136.39% | -122.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 532.48% | 717.57% | 1,512.84% | 136.39% | -122.54% |
| Cost of Revenue | 242.59% | 294.66% | 10,528.83% | 107.53% | -132.39% |
| Gross Profit | -101.63% | -131.06% | -567.78% | -61.73% | 141.13% |
| SG&A Expenses | 259.83% | 2,807.16% | 30.12% | -27.79% | -114.40% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 182.68% | 250.65% | 324.55% | 0.11% | -129.29% |
| Operating Income | -142.73% | -194.98% | -206.80% | 16.19% | 130.33% |
| Income Before Tax | -107.13% | -111.56% | -115.77% | -143.03% | 185.06% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -107.22% | -111.68% | -115.88% | -143.27% | 185.04% |
| Earnings from Discontinued Operations | 2.23% | -65.07% | -371.27% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.80% | -23.91% | -320.81% | -106.14% | 61.87% |
| EBIT | -142.73% | -194.98% | -206.80% | 16.19% | 130.33% |
| EBITDA | -149.03% | -212.46% | -157.40% | 15.07% | 128.20% |
| EPS Basic | -29.15% | -23.20% | -293.13% | -100.97% | 63.81% |
| Normalized Basic EPS | -152.96% | -211.71% | -172.13% | 29.35% | 127.76% |
| EPS Diluted | -83.80% | -61.97% | -800.86% | -161.53% | 74.61% |
| Normalized Diluted EPS | -143.01% | -177.04% | -3,619.17% | 7.79% | 134.19% |
| Average Basic Shares Outstanding | 2.40% | 2.74% | 2.77% | 2.54% | 2.45% |
| Average Diluted Shares Outstanding | -4.76% | -4.49% | -4.51% | -4.77% | 10.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
